Home » Posts tagged 'daily mail'
Tag Archives: daily mail
Daily Mail – Justin Urquhart Stewart: Co-founder, Seven Investment Management tips Cadence Minerals at 28p
From the Daily Mail. Share picks for the cautious and the brave for 2022: As investors eye an anwkward year ahead, we ask three experts for their stock ideas.
For the brave: Cadence Minerals (28p)
This is a riskier investment as it is not just a corporate story but involves politics as well. Cadence (formerly known as Rare Earth Minerals) is not a mining company but bears more resemblance to an investment trust made up of rare earth mining companies. 
Rare earth minerals are in high demand but are often difficult to extract. Sometimes this is due to geology, but more often because of geography. Often they are from developing nations with poor infrastructure alongside an unreliable political backdrop.
The largest deposits are in China, and having your investments reliant upon the Communist party there may not be the best position for your portfolio. Cadence reduces risk by giving you a basket of rare earth mining companies and most of its assets are outside the direct clutches of the Chinese authorities directly.
One is in the Czech Republic, where Cadence has a significant holding in a lithium mine. This is a longer-term investment. Success will come if the portfolio companies show their mines are money makers and not just money pits.
Link here to view online
Daily Mail – The volunteers who are DELIBERATELY catching Covid: 2,500 Britons will take part in the world’s first ‘human challenge trials’ run by Imperial College next month in bid to accelerate research on pandemic
by Faith Ridler
The volunteers who are DELIBERATELY catching Covid: 2,500 Britons will take part in the world’s first ‘human challenge trials’ run by Imperial College next month in bid to accelerate research on pandemic
- Alex Greer, 20, will take part in the human challenge trials in London next month
- Those in the study will receive a vaccine before being exposed to coronavirus
- Volunteers, aged 18 to 30, will be paid up to £4,000 for two-to-three week stay
Around 2,500 Britons will deliberately be infected with coronavirus in the world’s first ‘human challenge trials’ which will begin next month in a bid to accelerate research on the pandemic.
Alex Greer, 20, is among those who have volunteered to take part in the research, which is due to begin at the Royal Free Hospital in London in January.
In the initial study, announced by the Government in October, around 90 volunteers under the age of 30 will receive a dose of an experimental nasal vaccine before being deliberately infected with Covid-19.
Professor Openshaw previously told BBC Radio 4’s Today programme the trials could give a ‘really firm idea’ of whether a vaccine will work and how it will work….
The Government has put £33.6million behind the challenge trials.
Imperial College London will sponsor the first part of the study, where volunteers are infected with Covid-19, before moving on to the second stage where vaccinated volunteers will be exposed to the virus.
The study is being designed by hVIVO, a subsidiary of Dublin-based pharmaceutical company Open Orphan, which today announced it had secured funding from the Government.
Link here to read the full Daily Mail article
Daily Mail – Stock Watch Open Orphan #ORPH October 30th
Daily Mail Stock Watch – Open Orphan #ORPH – October 30th 2020
Daily Mail Stock Watch – Cadence Minerals
Mining investment group Cadence Minerals #KDNC surged after a court in Brazil ruled it can start shipping stockpiled iron ore.
Cadence and its joint venture partners are in talks with potential ore buyers.
The cash will be used on studies needed to reopen the Amapa mine, which was previously owned by Anglo American.
Shares in Cadence, whose chairman Andrew Suckling said the ruling brings Amapa ‘back to life’, jumped 73.9 per cent, or 2.4p, to 5.65p.
Link here to original article by Francesca Washtell
Race to stop the world getting sick: As coronavirus ravages the globe, experts work around the clock developing vaccines and trialling drugs in a desperate attempt to contain it
by Pat Hagan, Daily MailAs the needle slipped into Jennifer Haller’s arm, the world watched and held its breath.
This was the moment last week when Jennifer became the first person to be injected with an experimental vaccine that scientists hope will help prevent future pandemics of the deadly Covid-19 coronavirus.
Mother-of-two Jennifer, 43, from Seattle, told reporters: ‘We all feel so helpless. But this is an amazing opportunity for me to do something.’
Over the next few months, hundreds more people — including many in the UK — are expected to sign up as human guinea pigs, just like Jennifer.
Last week, Boris Johnson announced that the first British patient has been put into a trial for drugs that may treat coronavirus. And a safety trial on humans, led by Oxford University, for a potential new vaccine is also expected to start next month.
This is part of a global effort, as the search gathers pace for new ways to detect, treat and prevent Covid-19.
Some, like Jennifer, will have vaccines that contain corona-like (albeit harmless) viruses injected into their bloodstream to see whether their immune systems can be trained to recognise and destroy the virus.
Others are likely to be deliberately infected with weaker versions of coronavirus and given a variety of drugs to try to stop it in its tracks. It will be science at Formula 1 pace — with some corners cut and rules bypassed.
But what does it mean to offer up your body for scientific exploration in the battle against the virus?
UK CENTRE RECRUITING HUNDREDS FOR TRIALS
In the UK, one of the centres leading the fight is FluCamp, a 24-bed privately run unit based in Whitechapel, East London, where for the past 30 years scientists have been carrying out research on cold and flu viruses.
It is the only research facility of its kind in Europe — and one of just four in the world — equipped to quarantine patients for weeks at a time while they are exposed to highly infectious viruses.
Confined to one room 24 hours a day for up to a fortnight, volunteers are subject to round-the-clock testing by health professionals clad in protective clothing.
FluCamp has announced plans to recruit hundreds of healthy volunteers over the next few months. The first stage is to select 24 participants and expose them to two virus strains that are related to Covid-19 but do not wreak the same degree of havoc on the body.
A spokesman said the clinic has been inundated with more than 20,000 enquiries from would-be human guinea pigs since it unveiled its plans on March 9.
Professor John Oxford, an expert in virology at Queen Mary, University of London and scientific adviser to hVivo — the company that runs FluCamp — says the selection process will begin in the next few weeks. ‘The plan is to test hundreds of patients but do 24 at a time, as that is how many beds the unit has,’ he says.
Link here for the full article
Would you bet on the big names breaking into China? British firms beating a path to Beijing.
Would you bet on the big names breaking into China? British firms beating a path to Beijing. – by Ruth Sunderland – Daily Mail
British businessmen in Beijing feel conditions are now right for UK companies to seize the upper hand over old rival Germany.
Clare Pearson of the China Britain Business Council says: ‘For the past 30 years Germany has been a good fit, because China needed agricultural equipment and other manufactured goods.’
However, China’s population is getting wealthier and older, which favours sectors where the UK is strong: insurance, financial services, leisure and fashion and Pearson adds: ‘This is a turning point for [China] to switch from Germany to the UK. In China, we are moving into a middle class era.’
Full article here